Universal prophylaxis compared with screen-and-treat for Chlamydia trachomatis prior to termination of pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 6, 2002, Pages 606-609

  Cameron, S T ^a   Sutherland, S ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DOXYCYCLINE; METRONIDAZOLE; NITROIMIDAZOLE; TETRACYCLINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BRACE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; ECTOPIC PREGNANCY; GONORRHEA; HUMAN; INFECTION RISK; INFERTILITY; MASS SCREENING; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; PREGNANCY TERMINATION; PRIORITY JOURNAL; VAGINITIS; COMPARATIVE STUDY; FEMALE; INDUCED ABORTION; METHODOLOGY; MICROBIOLOGY; PREGNANCY; PUERPERAL INFECTION; VAGINA DISEASE;

ABORTION, INDUCED; ANTIBIOTIC PROPHYLAXIS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PUERPERAL INFECTION; VAGINAL DISEASES;

EID: 0142227807     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2002.01009.x     Document Type: Article

References (32)

1. Office for National Statistics. Health Statistics Spring, 1999.
2. Abortion Statistics. 1999;ISD Publications, Edinburgh.
3. Abortion Provision in Britain: How Services are Provided and How They Could be Improved. 1997;Birth Control Trust, London.
4. Penney G.C., Thomson M., Norman Jet al. A randomised comparison of strategies for reducing infective complications of induced abortion. Br J Obstet Gynaecol. 105:1998;599-604.
5. Blackwell A.L., Thomas P.D., Wareham K., Emery S.J. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet. 342:1993;206-210.
6. Recommendations arising from the 31st RCOG Study Group 1996. The prevention of pelvic infection. London: RCOG Press.
7. Howe L., Wiggins R., Millar M.R., Horner P.J., Caulfield A.P. Mucinase and sialidase activity of the vaginal microflora: implications for the pathogenesis of preterm labour. Int J STD AIDS. 10:1999;442-447.
8. Crowley T., Low N., Turner A., Harvey I., Bigwood K., Horner P. Antibiotic prophylaxis to prevent post-abortal upper genital tract infection in women with bacterial vaginosis; randomised controlled trial. Br J Obstet Gynaecol. 108:2001;396-402.
9. Vejtorp M., Bollerrup A.C., Vjetorp Let al. Bacterial vaginosis: a double-blind randomised trial of the effect of treatment of the sexual partner. Br J Obstet Gynaecol. 95:1988;920-926.
10. Egger M., Low N., Smith G.D., Lindblom B., Herrman B. Screening for chlamydial infections and risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ. 316:1998;1776-1780.
11. Schachter J. Which test is best for chlamydia? Curr Opin Infect Dis. 12:1999;41-45.
12. Duncan B., Hart G., Scoular A., Bigrigg A. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ. 322:2001;195-199.
13. Grimes D.A., Cates W. Complications from legally induced abortion: a review. Obstet Gynecol Surv. 34:1979;177-191.
14. The Care of Women Requesting Abortion. 2000;RCOG Press, London.
15. Cameron S.T., Stewart S., Sutherland S. Audit of screen-and-treat policy for Chlamydia trachomatis infection amongst women having a termination of pregnancy. J Reprod Fertil. (abstract series no. 25):2000;62.
16. Cameron S.T., Glasier A.F., Logan J., Benton L., Baird D.T. The impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh. Br J Obstet Gynaecol. 103:1996;1222-1229.
17. Henshaw R.C., Nadji S.A., Russell I.T., Templeton A.A. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Hum Reprod. 9:1994;2167-2172.
18. Hakim-Elahi E., Tovell H.M., Burnhill M.S. Complications of first trimester abortion: a report of 170,000 cases. Obstet Gynecol. 76:1990;129-135.
19. Sawaya G.F., Grady D., Kerlikowske, Grimes D.A. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol. 87:1996;884-890.
20. Blythe M.J., Katz B.P., Batteiger BEet al. Recurrent genitourinary chlamydial infections in sexually active female adolescents. J Paediatr. 121:1992;487-493.
21. Whittington W.L., Kent C., Kissinger Pet al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis. 28:2001;117-123.
22. Patton D.L., Wolner-Hanssen P., Cosgrove SJet al. The effects of Chlamydia trachomatis on the female reproductive tract of the macara memestrina after a single tubal challenge following repeated inoculations. Obstet Gynecol. 76:1990;643-650.
23. Standards for partner notification. Clinical Guidelines' Genital Chlamydial Infections' Central Audit Group in Genitourinary Medicine. 1997;Health Education Authority, A1 Technical Publication Services, London.
24. Cowan F.M., French R., Johnston A.M. The role and effectiveness of partner notification in STI control: a review. Genitourin Med. 72:1996;247-252.
25. Huengsberg M., Mullis D., Gray J., Sawers R.S., Radcliffe K.W. Liaison between gynaecologists, microbiologists and genitourinary medicine clinics in the management of patients with genital chlamydia and gonococcal infections. Int J STD AIDS. 9:1998;162-163.
26. Andersen B., Ostergaard L., Moller J.K., Olesen F. Home sampling versus conventional contact tracing for detecting Chlamydia trachomatis infection in male partners of infected women: randomised study. BMJ. 316:1998;350-351.
27. Kissinger P., Brown R., Reed Ket al. Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect. 74:1998;331-333.
28. Ramstedt K., Forssman L., Johannisson G. Contact tracing in the control of genital Chlamydia trachomatis infection. Int J STD AIDS. 2:1991;116-118.
29. Agacfidan A., Moncada J., Schachter J. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother. 37:1993;1746-1748.
30. Stamm W.E., Hicks C.B., Martin DHet al. Azithromycin for empirical treatment for nongonoccocal urethritis syndrome in men: a randomised double-blind study. JAMA. 274:1995;545-549.
31. Hillis S.D., Coles F.B., Litchfield Bet al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings. Sex Transm Dis. 25:1998;5-11.
32. Bachmann L.H., Stephens J., Richey C.M., Hook E.W. Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success despite poor compliance. Sex Transm Dis. 26:1999;272-278.